Komipharm International Co. Ltd (041960) — Capital Reinvestment Ratio
Komipharm International Co. Ltd (041960) has a Capital Reinvestment Ratio of 1.95x as of December 2025, meaning it reinvests 2% of its operating cash flow (₩946.94 Million) in capital expenditures (₩1.85 Billion). Check 041960 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Komipharm International Co. Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Komipharm International Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Komipharm International Co. Ltd.
Annual Capital Reinvestment Ratio for Komipharm International Co. Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Komipharm International Co. Ltd from 2013 to 2024. See cash generation quality of Komipharm International Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.3% |
| 2020 | 65.70x | ₩25.20 Million | ₩1.66 Billion | ▲ +988.4% |
| 2019 | 6.04x | ₩950.79 Million | ₩5.74 Billion | ▼ -46.9% |
| 2017 | 11.37x | ₩235.64 Million | ₩2.68 Billion | ▲ +12.3% |
| 2016 | 10.13x | ₩1.21 Billion | ₩12.24 Billion | ▲ +59.8% |
| 2013 | 6.34x | ₩3.93 Billion | ₩24.93 Billion | — |